Valuation QuidelOrtho Corporation

Equities

Real-time Estimate Cboe BZX Other stock markets 14:42:54 13/03/2026 GMT			5-day change	1st Jan Change
17.98 ^USD	+0.31%		-14.55%	-37.68%

02-16	QuidelOrtho Corporation Enters Strategic Supply Agreement to Expand Global Immunoassay Portfolio	CI
02-13	Joseph M. Busky to Retire as Principal Financial Officer of Quidelortho Corporation, Effective as of June 30, 2026	CI

Data adjusted to current consolidation scope

Fiscal Period: December	2021	2022	2023	2024	2025	2026	2027	2028
Capitalization ¹	5,291	5,474	5,013	2,976	1,990	1,220	-	-
Change	-	3.46%	-8.42%	-40.64%	-33.12%	-38.7%	-	-
Enterprise Value (EV) ¹	4,463	7,768	7,261	5,361	4,471	3,557	3,275	2,941
Change	-	74.05%	-6.53%	-26.17%	-16.6%	-20.44%	-7.92%	-10.19%
P/E ratio	7.73x	8.67x	-500x	-1.47x	-1.76x	-11.4x	-37.3x	-57.1x
PBR	2.75x	1.12x	1x	0.99x	-	0.61x	0.58x	0.54x
PEG	-	-0.2x	5x	-0x	0x	0.1x	0.5x	1.6x
Capitalization / Revenue	3.12x	1.68x	1.67x	1.07x	0.73x	0.44x	0.42x	0.41x
EV / Revenue	2.63x	2.38x	2.42x	1.93x	1.64x	1.28x	1.14x	0.98x
EV / EBITDA	4.48x	5.84x	10x	9.87x	7.49x	5.53x	4.64x	3.86x
EV / EBIT	4.93x	9.21x	52.2x	16x	11.8x	8.91x	6.94x	5.66x
EV / FCF	8.7x	10.4x	26.9x	-47.8x	-53.9x	9.17x	6.91x	5.7x
FCF Yield	11.5%	9.58%	3.71%	-2.09%	-1.86%	10.9%	14.5%	17.5%
Dividend per Share ²	-	-	-	-	-	-	-	-
Rate of return	-	-	-	-	-	-	-	-
EPS ²	16.43	9.56	-0.15	-30.16	-16.69	-1.573	-0.4808	-0.3137
Distribution rate	-	-	-	-	-	-	-	-
Net sales ¹	1,699	3,266	2,998	2,783	2,730	2,774	2,882	3,012
EBITDA ¹	995.6	1,331	723.2	542.9	597	643.7	706.6	762.2
EBIT ¹	906.1	843.7	139.1	335.8	379.3	399.3	472.1	519.2
Net income ¹	704.2	548.7	-10.1	-2,027	-1,132	-108	-33.06	-21.43
Net Debt ¹	-828.5	2,293	2,247	2,385	2,480	2,337	2,055	1,721
Reference price ²	126.97	82.89	75.03	44.25	29.30	17.92	17.92	17.92
Nbr of stocks (in thousands)	41,675	66,045	66,819	67,257	67,932	68,082	-	-
Announcement Date	17/02/22	15/02/23	13/02/24	12/02/25	11/02/26	-	-	-

¹USD in Million²USD

Estimates

Add to a list 0 selected To use this feature you must be a member Log in Sign up	P/E (N)	EV / Sales (N)	EV / EBITDA (N)	Dividend Yield (N)	Capi.($)
QUIDELORTHO CORPORATION	-11.39x	1.28x	5.53x	-.--%	1.22B
SARTORIUS AG	58.13x	4.46x	15.04x	0.39%	15.31B
INNER MONGOLIA FURUI MEDICAL SCIENCE CO., LTD.	77.3x	-	-	1.15%	2.12B
ECKERT & ZIEGLER SE	13.5x	2.6x	8.77x	1.28%	1.07B
SHANGHAI AOHUA PHOTOELECTRICITY ENDOSCOPE CO., LTD.	160.2x	-	-	0.49%	785M
REVENIO GROUP OYJ	24.57x	4.12x	13.59x	2.4%	547M
VAREX IMAGING CORPORATION	17.75x	-	-	-	455M
CELLAVISION AB	23.59x	4.58x	14.38x	1.74%	388M
Average	45.46x	3.41x	11.46x	1.06%	2.74B
Weighted average by Cap.	55.30x	4.14x	14.00x	0.57%